Education
About Us
Working with TipRanks
Follow Us
Essex Bio-Technology Limited (HK:1061)
:1061
RESEARCH TOOLSreports
1061 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$2.15 - HK$5.43
Previous CloseN/A
Volume76.00K
Average Volume (3M)1.55M
Market Cap
HK$2.68B
Enterprise ValueHK$2.31B
Total Cash (Recent Filing)HK$560.74M
Total Debt (Recent Filing)HK$187.04M
Price to Earnings (P/E)8.7
Beta0.43
Next Earnings
Aug 26, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 23, 2025Dividend Yield2.54%
Share Statistics
EPS (TTM)0.54
Shares Outstanding567,006,000
10 Day Avg. Volume766,490
30 Day Avg. Volume1,547,416
Financial Highlights & Ratios
PEG Ratio0.59
Price to Book (P/B)1.27
Price to Sales (P/S)0.00
P/FCF Ratio8.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$5.00Price Target Upside5.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Essex Bio-Technology News
PremiumCompany Announcements
Essex Bio-Technology Establishes New Nomination Committee
PremiumCompany Announcements
Essex Bio-Technology AGM Resolutions Successfully Passed
PremiumCompany Announcements
Essex Bio-Technology Announces AGM and Key Resolutions
PremiumCompany Announcements
Essex Bio-Technology Proposes Amendments to Articles of Association
PremiumCompany Announcements
Essex Bio-Technology Reports Strong Profit Growth Despite Turnover Decline
PremiumCompany Announcements
Essex Bio-Technology Declares Final Dividend for 2024Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.60%
Mutual Funds
― Other Institutional Investors
99.27% Public Companies and
Individual Investors
1061 FAQ
What was Essex Bio-Technology Limited’s price range in the past 12 months?
Essex Bio-Technology Limited lowest stock price was HK$2.15 and its highest was HK$5.43 in the past 12 months.
What is Essex Bio-Technology Limited’s market cap?
Essex Bio-Technology Limited’s market cap is HK$2.68B.
When is Essex Bio-Technology Limited’s upcoming earnings report date?
Essex Bio-Technology Limited’s upcoming earnings report date is Aug 26, 2025 which is in 40 days.
How were Essex Bio-Technology Limited’s earnings last quarter?
Currently, no data Available
Is Essex Bio-Technology Limited overvalued?
According to Wall Street analysts Essex Bio-Technology Limited’s price is currently Undervalued.
Does Essex Bio-Technology Limited pay dividends?
Essex Bio-Technology Limited pays a Semiannually dividend of HK$0.06 which represents an annual dividend yield of 2.54%. See more information on Essex Bio-Technology Limited dividends here
What is Essex Bio-Technology Limited’s EPS estimate?
Essex Bio-Technology Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Essex Bio-Technology Limited have?
Essex Bio-Technology Limited has 567,006,000 shares outstanding.
What happened to Essex Bio-Technology Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Essex Bio-Technology Limited?
Currently, no hedge funds are holding shares in HK:1061
Essex Bio-Technology Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$5.00 (5.93% Upside)
HK$5.00 (5.93% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
98.06%
12-Months-Change
Fundamentals
Return on Equity
15.18%
Trailing 12-Months
Asset Growth
5.50%
Trailing 12-Months
Company Description
Essex Bio-Technology Limited
Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally. The company operates through Ophthalmic Products and Surgical Products segments. It researches and develops basic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration. The company offers Beifushu series, such as Beifushu eye drops, Beifushu eye gel, and Beifushu unit-dose eye drops; Tobramycin eye drops, Levofloxacin eye drops, and Sodium Hyaluronate eye drops, as well as Iodized Lecithin Capsules. It also provides Beifuji sprays and lyophilized powder, and Beifuxin gels for use in burn and scald wounds, acute wounds, surgical incisions, chronic wounds, skin grafting, and other applications. In addition, it offers ophthalmic and surgical products from third parties. Further, the company offers Carisolv dental caries removal gel; and Yi Xue An Granules. It has license agreements with Mitotech S.A. and Mitotech LLC. The company was founded in 1990 and is headquartered in Zhuhai, China.
Technical Analysis
China Traditional Chinese Medicine Holdings Co
―
Sihuan Pharmaceutical Holdings Group
―
Consun Pharmaceutical Group Ltd.
―
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
―
China Shineway Pharmaceutical Group Limited
―